Vyome Holdings, Inc. (HIND)

Official site

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$1.90

-0.03 (-1.55%)

Market Cap: $13.55M

Last updated: Oct 16, 2026 at 1:55 PM ET

Earnings

Performance (10Y)

Beat Rate

63%(10/16)

Avg Surprise

-426.40%

Streak

3 Q

Upcoming Estimates

Period ending Sep 30, 2026

EPS Consensus$-0.20

Range$-0.23 - $-0.16

2 analysts

EPS RevisionsNo revisions (7d)No revisions (30d)

EPS Estimate DriftChange to current

90d ago$-0.21+7.1%

60d ago$-0.21+7.1%

30d ago$-0.21+7.1%

7d ago$-0.16-21.9%

Current$-0.20

Revenue Consensus

Range$0 - $0

2 analysts

Period ending Dec 31, 2026

EPS Consensus$-0.09

Range$-0.29 - $0.04

3 analysts

Revenue Consensus

$103000

Range$90000 - $119000

3 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$-0.09	$-0.29 - $0.04	-	-	3	-	-
Sep 30, 2026Sep 26EST	-	$-0.20	$-0.23 - $-0.16	-	-	2	No revisions (30d)	-
Jun 30, 2026Jun 26 Reported Aug 12, 2026Reported Aug 12	$-0.10	$-0.19	$-0.19 - $-0.19	+47.37%	Beat	1	1 0 30d	+98.9%
Mar 31, 2026Mar 26 Reported May 12, 2026Reported May 12	$-0.14	$-0.18	$-0.18 - $-0.18	+20.06%	Beat	1	1 0 30d	+94.2%
Dec 31, 2025Dec 25 Reported Mar 26, 2026Reported Mar 26	$-0.21	$-0.34	$-0.34 - $-0.34	+39.12%	Beat	1	No revisions (30d)	+99.9%
Sep 30, 2025Sep 25 Reported Nov 14, 2025Reported Nov 14	$-3.12	$-0.11	$-0.11 - $-0.11	-2736.36%	Miss	1	No revisions (30d)	+99.1%
Jun 30, 2025Jun 25 Reported Aug 14, 2025Reported Aug 14	$-9.00	N/A	-	N/A	Beat	-	-	+98.3%
Mar 31, 2025Mar 25 Reported Apr 4, 2025Reported Apr 4	$-2.47	$-0.07	-	-3428.57%	Miss	-	-	+100.0%
Sep 30, 2024Sep 24 Reported Nov 14, 2024Reported Nov 14	$-310.70	N/A	-	N/A	Beat	-	-	+95.0%
Jun 30, 2024Jun 24 Reported Aug 14, 2024Reported Aug 14	$-366.78	N/A	-	N/A	Beat	-	-	-978.1%
Mar 31, 2024Mar 24 Reported Apr 1, 2024Reported Apr 1	$-542.24	N/A	-	N/A	Beat	-	-	-92590.6%
Sep 30, 2023Sep 23 Reported Nov 8, 2023Reported Nov 8	$-5936.62	N/A	-	N/A	Beat	-	-	-1175468.2%
Jun 30, 2023Jun 23 Reported Aug 7, 2023Reported Aug 7	$-6235.08	N/A	-	N/A	Beat	-	-	-1633403.6%
Mar 31, 2023Mar 23 Reported May 15, 2023Reported May 15	$-34.02	$-10.00	-	-240.20%	Miss	-	-	-1866.5%
Sep 30, 2022Sep 22 Reported Nov 14, 2022Reported Nov 14	$-0.58	N/A	-	+98.20%	Beat	-	-	-91.1%
Jun 30, 2022Jun 22 Reported Aug 19, 2022Reported Aug 19	$-0.51	$-0.51	-	+0.98%	Beat	-	-	-245.4%
Mar 31, 2022Mar 22 Reported May 23, 2022Reported May 23	$-0.38	$-0.34	-	-10.64%	Miss	-	-	+71.1%
Dec 31, 2021Dec 21 Reported Mar 28, 2022Reported Mar 28	$-1.73	$-0.17	-	-888.57%	Miss	-	-	-239.2%
Sep 30, 2021Sep 21 Reported Nov 11, 2021Reported Nov 11	$-0.31	$-0.15	-	-104.07%	Miss	-	-	+49.8%
Jun 30, 2021Jun 21 Reported Aug 16, 2021Reported Aug 16	$-0.15	$-0.22	-	+33.55%	Beat	-	-	+91.0%
Mar 31, 2021Mar 21 Reported May 12, 2021Reported May 12	$-1.32	N/A	-	N/A	Beat	-	-	+35.3%
Dec 31, 2020Dec 20 Reported Mar 12, 2021Reported Mar 12	$-0.51	N/A	-	+83.00%	Beat	-	-	+100.0%
Sep 30, 2020Sep 20 Reported Nov 6, 2020Reported Nov 6	$-0.61	N/A	-	+82.57%	Beat	-	-	+100.0%
Jun 30, 2020Jun 20 Reported Jul 30, 2020Reported Jul 30	$-1.63	N/A	-	+89.13%	Beat	-	-	+100.0%
Mar 31, 2020Mar 20 Reported Jun 19, 2020Reported Jun 19	$-2.04	N/A	-	+92.00%	Beat	-	-	+100.0%
Dec 31, 2019Dec 19 Reported Feb 27, 2020Reported Feb 27	$-555633.92	N/A	-	N/A	Beat	-	-	+44.4%
Sep 30, 2019Sep 19 Reported Nov 8, 2019Reported Nov 8	$-531940.09	N/A	-	N/A	Beat	-	-	+46.8%
Jun 30, 2019Jun 19 Reported Jul 24, 2019Reported Jul 24	$-1000000.00	N/A	-	N/A	Beat	-	-	+0.0%
Mar 31, 2019Mar 19 Reported May 10, 2019Reported May 10	$-1000000.00	N/A	-	N/A	Beat	-	-	+0.0%
Dec 31, 2018Dec 18 Reported Feb 22, 2019Reported Feb 22	$-1000000.00	N/A	-	N/A	Beat	-	-	+0.0%
Sep 30, 2018Sep 18 Reported Nov 2, 2018Reported Nov 2	$-1000000.00	N/A	-	N/A	Beat	-	-	+0.0%
Jun 30, 2018Jun 18 Reported Aug 2, 2018Reported Aug 2	$-1000000.00	N/A	-	N/A	Beat	-	-	+0.0%
Mar 31, 2018Mar 18 Reported May 10, 2018Reported May 10	$-1000000.00	N/A	-	N/A	Beat	-	-	+0.0%
Dec 31, 2017Dec 17 Reported Mar 5, 2018Reported Mar 5	$-1000000.00	N/A	-	N/A	Beat	-	-	+0.0%
Sep 30, 2017Sep 17 Reported Nov 3, 2017Reported Nov 3	$-1000000.00	N/A	-	N/A	Beat	-	-	-
Jun 30, 2017Jun 17 Reported Aug 2, 2017Reported Aug 2	$-1000000.00	N/A	-	N/A	Beat	-	-	-
Mar 31, 2017Mar 17 Reported May 10, 2017Reported May 10	$-1000000.00	N/A	-	N/A	Beat	-	-	-
Dec 31, 2016Dec 16 Reported Feb 23, 2017Reported Feb 23	$-1000000.00	N/A	-	N/A	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	-0.53	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	0.00%	Operating Margin	-3200.00%
ROE	-999.00%	ROIC	N/A
Financial Health
Debt/Equity	0.00x	Interest Coverage	-61.57x
Current Ratio	4.37x	Quick Ratio	4.37x
Trading Statistics
Beta	N/A	Avg Volume	20.84K
52-Week High	$6.56	52-Week Low	$1.75

Technical Indicators Dashboard

Moving Averages

SMA 10$1.99

SMA 20$1.99

SMA 50$2.10

SMA 200$2.33

EMA 10$1.98

EMA 20$2.00

EMA 50$2.06

EMA 200$3.76

MACD

Line: -0.03Signal: -0.03Hist: -0.00

ADX

ADX: 9.2+DI: 18.7-DI: 22.6

Aroon & PSAR

Aroon Up24.0

Aroon Down64.0

PSAR$2.09

Bollinger Bands

Upper Band$2.12

Lower Band$1.87

%B Position1281%(Upper)

Band Width0.14

RSI (14-Day)

Neutral

39.8

Momentum Oscillators

Stoch %K42.0

Stoch %D57.6

Williams %R-70.4

ROC (10d)-1.0%

Momentum-0.02

CCI (20d)-162.6

MFI (14d)31.3

Volatility Measures

ATR (14d)$0.10(5.3%)

StdDev (20d)0.06

Hist Vol56.0%(High)

Volume Flow

VWAP$1.89

OBV515.8M

AD Line259.2B

CMF (20d)0.031

Volume Metrics

Avg Vol (20d)22.4K

Vol Ratio0.7x

VWMA (20d)$2.03

Pivot Points

R3$2.04

R2$2.01

R1$1.97

Pivot Point$1.94

S1$1.90

S2$1.87

S3$1.83

Advanced Oscillators

TSI-10.72

Ultimate Osc49.2

KST-56.13

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$26,955	$31,591	$-2,069,913	$34,627	$49,954	$198,581	$-3,736,582	$84,526	$1.97M	$1.94M	$1.98M	$2.15M
Cost of Revenue	$15,297	$14,946	$-990,634	$16,577	$25,719	$44,162	$-1,595,467	$47,441	$831,000	$779,000	$140,000	$867,000
Gross Profit	$11,658	$16,645	$-1,079,279	$18,050	$24,235	$154,419	$-2,141,115	$37,085	$1.13M	$1.17M	$1.84M	$1.29M

Operating Expenses	$874,224	$1.15M	$-4,169,019	$8.59M	$348,424	$353,417	$-5,679,753	$318,063	$3.19M	$3.38M	$3.74M	$5.17M
R&D	$506,723	$666,405	$-291,419	$39,677	$80,061	$90,268	$-664,424	$66,815	$399,000	$484,000	$739,000	$542,000
SG&A	$364,891	$477,575	$-1,696,779	$844,344	$265,395	$259,626	$-3,126,249	$246,821	$1.91M	$1.87M	$-4,549,000	$3.85M
Operating Income	$-862,566	$-1,129,940	$3.09M	$-8,574,310	$-324,189	$-198,998	$3.54M	$-280,978	$-2,054,000	$-2,210,000	$-1,896,000	$-3,880,000

Interest Income	$0	$0	$0	$0	$0	$0	$0	$0	$4,000	$9,000	$17,000	$5,000
Interest Expense	$3,325	$2,845	$145,037	$25,604	$56,139	$54,954	$589,262	$45,742	$-429,000	$0	$0	$0
Income Before Tax	$-719,683	$-985,521	$-741,413	$-8,595,300	$-308,760	$-293,974	$2.86M	$-548,410	$-1,580,000	$-2,179,000	$-1,667,000	$-3,531,000
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$15,000	$14,000	$31,000	$3,000

Net Income	$-719,683	$-985,521	$-726,413	$-8,595,300	$-308,760	$-293,974	$2.89M	$-547,772	$-1,595,000	$-2,193,000	$-1,698,000	$-3,534,000

EBITDA	$-713,748	$-980,071	$-615,688	$-8,568,399	$-249,653	$-235,497	$3.47M	$-501,185	$-2,007,000	$-2,182,000	$-1,669,000	$-3,486,000
EBIT	$-716,358	$-982,676	$-618,376	$-8,569,696	$-252,621	$-239,020	$3.46M	$-502,668	$-2,013,000	$-2,188,000	$-1,676,000	$-3,536,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about HIND

News

No news available

Company news will appear here when available

HIND Valuation and Fair Value

P/E: -0.5x
P/B: 2.2x

See GNG's fair value

HIND Profitability: Margins, ROIC and FCF

Gross margin: 52.3%
Operating margin: -3200.0%
Net margin: 0.0%
ROE: -999.0%

HIND Competitors

Company	Ticker
Citius Pharmaceuticals Inc	CTXR
Tvardi Therapeutics, Inc.	TVRD
SINTX Technologies Inc	SINT
Biofrontera Inc	BFRI
Estrella Immunopharma Inc.	ESLA
Femasys Inc	FEMY
Pasithea Therapeutics Corp	KTTA
GT Biopharma Inc	GTBP

Sector: Healthcare

HIND Analyst Ratings

Consensus: Buy
Analysts: 3
Strong Buy: 1
Buy: 2
Hold: 0
Sell: 0
Strong Sell: 0

HIND Bull Case vs Bear Case

Bear case

HIND's quarterly revenue changed -46.0% year over year.

HIND Earnings: Beat Rate and Next Report

Beat rate: 5 of 8 quarters (62.5%)
Average surprise: -774.9%
EPS estimate (fiscal period ending Sep 30, 2026): $-0.20
Estimate revisions (30 days, fiscal period ending Sep 30, 2026): 0 up, 0 down

Frequently Asked Questions About HIND

Does HIND pay dividends?

Vyome Holdings, Inc. (HIND) does not currently pay a regular dividend.

What is HIND's market cap?

Vyome Holdings, Inc. (HIND) has a market capitalization of $13.55M with a current stock price of $1.90.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In